Results 71 to 80 of about 29,629 (128)

Translational Oncogenomics and Human Cancer Interactome Networks [PDF]

, 2011
An overview of translational, human oncogenomics, transcriptomics and cancer interactomic networks is presented together with basic concepts and potential, new applications to Oncology and Integrative Cancer Biology.
I. C. Baianu
core   +1 more source

Stronger inflammatory/cytotoxic T cell response in women identified by microarray analysis [PDF]

, 2008
Women develop chronic inflammatory autoimmune diseases like lupus more often than men. The mechanisms causing the increased susceptibility are incompletely understood, although estrogen is believed to contribute.
Anura Hewagama, Bruce C. Richardson, Dipak Patel, Faith M. Strickland, Sushma Yarlagadda   +4 more
core   +1 more source

Crosstalk between cAMP and MAP Kinase Signaling in the Regulation of Cell Proliferation

, 2002
Hormonal stimulation of cyclic adenosine monophosphate (cAMP) and the cAMP-dependent protein kinase PKA regulates cell growth by multiple mechanisms.
Altschuler, Ambrosini, Arai, Arslan, Barberis, Barnier, Blanco-Aparicio, Bos, Boucher, Burgering, Burgun, Busca, Caron, Cass, Chen, Chen, Chen, Cheng, Chiloeches, Ciullo, Cole, Cook, Cook, Cospedal, Crepieux, Crespo, Crespo, D'Angelo, Daaka, de Rooij, Deeble, Depoortere, Dhillon, Dremier, Dugan, Feliciello, Filippa, Gonzalez-Robayna, Gottesman, Graves, Greenberg, Grewal, Grewal, Howe, Hsueh, Hu, Iacovelli, Iida, Kahan, Kao, Katagiri, Kato, Kawasaki, Kievit, Kim, Kitayama, Kobierski, Kubicek, L'Allemain, LaBaer, Lee, Lindquist, MacNicol, Mason, McKenzie, Mei, Mikula, Mischak, Misra-Press, Morice, Mutoh, Myklebust, Naderi, Ohba, Osinski, Patterson, Pham, Piiper, Plevin, Qiu, Quilliam, Reedquist, Ribeiro-Neto, Richards, Rommel, Saxena, Schmitt, Schmitt, Schmitt, Scott, Sebzda, Seger, Sevetson, Sidovar, Swanson, Thoresen, Thorson, Tsukamoto, Tsygankova, Tsygankova, Vaillancourt, van Oirschot, Verheijen, Vogt Weisenhorn, von Lintig, Vossler, Wan, Wang, Wellbrock, Wojnowski, Wu, Yamaguchi, Yarwood, Yee, Yonehara, York, Young, Zanassi, Zhang, Zimmermann, Zou, Zwartkruis, Zwartkruis   +122 more
core   +1 more source

Functional regulation of the Neurofibromatosis 2 tumor suppressor merlin [PDF]

, 2011
Neurofibromatosis 2 (NF2) is an autosomal dominant disorder manifested by the formation of multiple benign tumors of the nervous system. Affected individuals typically develop bilateral vestibular schwannomas which lead to deafness and balance disorders.
Pehrsson, Minja
core  

SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics. [PDF]

Int J Mol Sci
Eom J, Chun Y, Chang HR.
europepmc   +1 more source

Unraveling the Impact of KRAS Accessory Proteins on Oncogenic Signaling Pathways. [PDF]

Cells
Garg V, Hofmann RNHM, Saleem M, Mirzaiebadizi A, Hashemi GS, Hameed T, Jooyeh B, Pudewell S, Mehrabipour M, Mosaddeghzadeh N, Piekorz RP, Ahmadian MR.   +11 more
europepmc   +1 more source

Impact of Co-Mutations and Genetic Variations on Malignancy Risk in RAS-Positive Indeterminate Thyroid Nodules: an Institutional Experience. [PDF]

Endocr Pathol
Wong LQ, Baloch ZW.
europepmc   +1 more source

The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion. [PDF]

Front Oncol
Xing Y, Qin G, Lin X, Chen S, Su Y, Lin T, Chen G.   +6 more
europepmc   +1 more source

Targeting MET and KRAS G12C co-occurring mutation in metastatic adenoid cystic carcinoma of the trachea: a case report. [PDF]

J Med Case Rep
Zhang L, Wang T, Xu Y, Ji Y, Nie K.
europepmc   +1 more source

PrP^C-Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation. [PDF]

Int J Mol Sci
Lee JK, Yoon JY, Lee JY, Lee SH.
europepmc   +1 more source